Sunday 11 October 2026 Export all ABBV data to Excel Powerpack

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

276.47 4.05 +1.49%
Market cap
$481.4B
P/E
78.1×
Fwd P/E
27.8×
Dividend yield
3.10%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

175.41 96.82 107.14 71.08
P/S ratio
6.87 6.61 6.13 6.91
P/FCF ratio
20.81 22.69 19.27 24.45
P/Operating CF
58.31 77.46 100.54 129.56
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
7.92 7.63 7.14 7.91
EV/EBITDA
20.90 19.39 18.52 19.91
EV/Operating CF
22.66 24.51 21.13 26.11
EV/FCF
24.01 26.18 22.44 27.97
Quick Ratio
0.47 0.41 0.52 0.49
Current Ratio
0.72 0.67 0.80 0.81
Net Debt/EBITDA
13.10 9.53 10.71 7.73
Debt/Assets
51.34% 50.39% 53.39% 52.42%
Debt/Equity
(26.45) (20.91) (11.02) (12.03)
Asset Turnover
0.43 0.45 0.46 0.47
Operating CF/Net income
37.76 2.92 5.59 0.95
Capex/Depreciation
(0.13) (0.17) (0.14) (0.17)
Interest Coverage
2.85 6.94 6.19 9.47
Research and Development Expense of Revenue
14.70% 15.52% 16.48% 13.80%
Selling, General and Administrative Expense of Revenue
22.62% 23.44% 23.85% 21.38%
Intangible Assets out of Total Assets
0.67 0.66 0.63 0.63
Share Based Compensation of Revenue
1.32% 0.94% 2.96% 0.98%
Graham Net Nets
(0.26) (0.27) (0.28) (0.24)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
0.57% 1.03% 0.93% 1.41%
Free Cash Flow Yield
4.81% 4.41% 5.19% 4.09%
Revenue per Share
8.92 9.39 8.48 9.60
Operating CF per Share
3.97 2.95 2.16 1.94
Capex per Share
(0.22) (0.19) (0.15) (0.18)
Free Cash Flow per Share
3.76 2.76 2.01 1.76
Cash per Share
3.21 2.96 5.31 3.71
Shareholders Equity per Share
(1.47) (1.82) (3.74) (3.33)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(1.47) (1.82) (3.74) (3.33)
Free Cash Flow
6,643.00 4,889.00 3,564.00 3,114.00
Working Capital
(10,852.00) (14,227.00) (8,571.00) (7,973.00)
Capital Expenditures
(381.00) (329.00) (265.00) (322.00)
Net Current Asset Value
(107,958.00) (108,126.00) (109,546.00) (107,334.00)
EV/EBIT
52.28 30.94 29.25 30.20
Capex to Sales
0.02 0.02 0.02 0.02
Price to Operating Income
45.30 26.81 25.11 26.39
Other line items
Average Receivables
12,120.50 11,754.00 12,478.00 13,230.50
Average Payables
32,055.50 33,339.50 32,407.50 32,773.00
Average Inventory
4,694.00 4,566.00 4,787.50 5,043.50
Average Assets
138,660.00 134,560.50 136,314.00 136,148.50
Average Common Equity
1,736.00 68.00 (2,575.00) (3,013.00)

Fold the line items

Columns are period end dates